Clinical research institutions, universities and academic medical centers, pharmaceutical companies, medical device manufacturers, and other health and life sciences industry organizations are focused on protecting and leveraging their investments in research, development and innovation. We provide critical counseling to help preserve your assets, mitigate regulatory risk and get your products to market as expediently as possible. From clinical trials and product design to premarket approval and product launch, our team of attorneys and other professionals guides you in carefully crafting clinical trial, licensing, research and development, and other agreements; obtaining appropriate patents or other intellectual property protection; obtaining FDA and other regulatory approvals; addressing reimbursement strategies; and preparing for product liability defenses. We help you take advantage of federal tax exemptions, strategically change clinical trial processes or product designs, and conduct evidence-based advocacy to enhance federal support for areas of distinction. We are recognized for our work with clients in the areas of orphan drugs, patient-focused drug development, pediatrics and Alzheimer’s disease, among many others, and work with you to develop and win approval of treatments and medications that address some of today’s most pressing, unmet needs. We have the experience to help bring innovation to the industry and, most importantly, to patients.

Insights & Events


Published Articles December 2023

DEA Updates: Three New Rules Every Pharmacist Should Know

1 min read  
Speaking Engagement Recap September 27, 2023

The Technology Revolution in Health Care is in Sight: Realizing an AI-driven, Compliant, Equitable, Connected Health Care Ecosystem - Webinar

A BioNJ and Faegre Drinker Co-Sponsored Event
1 min read  
Published Articles August 2023

Ilse Peterson and Fatou Sarr Highlight COVID-19 Impacts on Neuromuscular Disease Community and Views Toward Telemedicine

1 min read  
Speaking Engagement Recap May 25, 2023

A (Brief) Quarter Century Look at NIH & Pediatric Research Funding, Policy & Politics...And What the Future May Hold

Children’s Hospital Pediatric Alliance 2023 Annual Research Meeting
1 min read  
Press Release February 2023

Faegre Drinker Elevates 6 Consulting Professionals to Principal

3 min read  
Published Articles January 2023

Meeting Report: The ALPHA Project — A Stakeholder Meeting on Lupus Clinical Trial Outcome Measures and the Patient Perspective

1 min read  
Updates July 2022

State AG Updates: New York, New Mexico, Washington State, Texas, Michigan & Multiple AGs in the Generic Pharmaceuticals Pricing Antitrust MDL

7 min read  
Published Articles May 2022

The Cure SMA Clinical Trial Experience Survey: A Study of Trial Participant Perspectives on Clinical Trial Management and Patient-Centric Management Practices

1 min read  
Updates March 2022

FDA Draft Guidance: Remote Data Acquisition in Clinical Investigations

4 min read  
Press Release December 2019

Sanjyot Sangodkar Joins FaegreBD in Washington, D.C.

1 min read  

Related Legal Services

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.